Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio
| Website | https://www.camenabio.com |
| Employees | 22 (16 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+12 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care |
| Keywords | Synthetic Biology, Gene Synthesis, Dna Synthesis, Biotechnology, Genes, Genetic Engineering, Molecular Biology, Biomanufacturing, Precision Medicine, Genome Editing, Biotechnology Services, Gene Editing Tools, Genetic Engineering Tools, Life Sciences, Drug Discovery, Agricultural Biotechnology, Biotechnology Research |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, Twist Bioscience, Syndax Pharmaceuticals, Geno, Zymergen, Inc., Strateos +36 more (view full list) |
Looking for a particular Camena Bioscience employee's phone or email?
Steve Harvey is the CEO of Camena Bioscience.
16 people are employed at Camena Bioscience.